AstraZeneca CEO Soriot says to work with new chairman for many years

FRANKFURT (Reuters) – Long-serving AstraZeneca boss Pascal Soriot said on Friday he expects to work with the new chairman-designate of the London-listed drugmaker, who will take over in 2023, for many years to come, suggesting he is not ready to retire.

The company said on Friday that Michel Demare will take over from outgoing Chairman Leif Johansson, who, like Soriot, has been in his leadership position for about a decade.

“Michel and I will be working together and forming an excellent team for the many years to come,” Soriot said on an analyst call after the company released its quarterly results.

(Reporting by Ludwig Burger and Natalie Grover; editing by Jason Neely)